ANO1 and neoplasm: We previously identified, by high-throughput screening, several small-molecule inhibitors and activators of TMEM16A Cl− conductance [9], [10], which have potential therapeutic value in cystic fibrosis, dry mouth, gastric hypomotility (activators), secretory diarrhea, pain and tumor growth (inhibitors).